Drawing for PLASMACUTE

USPTO serial 76490129

PLASMACUTE

Reviewed by CopyMark Law Group

Reg. 2996338Status 710
Filing date
Status date
Registration date
Sep 20, 2005
Examiner
RIRIE, VERNA BETH
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with PLASMACUTE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Clark W. Lackert

CLARK W LACKERT KING AND SPALDING LLP1185 AVE OF THE AMERICAS FL 35NEW YORK, NY 10036-2686UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
010Medical diagnostic apparatus and instruments, namely automatic, semi-automatic and manual cell-separation and sample-handling instruments, ELISA (Enzyme Linked Immuno Sorbent Assay) processors, immunoassay analyzers and rapid immunoassay analyzersSECTION 8 - CANCELLED—
042Scientific research in the fields of medical microbiology and immunology both in humans and animals; design and testing of new products for others; research related to biotechnology; development of new technology for others in the fields of medicine, clinical diagnostics, sample processing and biotechnology; medical and scientific diagnostic research services conducted for clinical fields trials for vaccines, and vaccine development and researchSECTION 8 - CANCELLED—
044Medical services related to diagnosticsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 21, 2012C8..CANCELLED SEC. 8 (6-YR)—
Sep 20, 2005R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 28, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 8, 2005NPUBNOTICE OF PUBLICATION—
Mar 15, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 11, 2005ALIEASSIGNED TO LIE—
Mar 4, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 2, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Jun 23, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 23, 2004MAILPAPER RECEIVED—
Apr 20, 2004CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 29, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 29, 2004MAILPAPER RECEIVED—
Aug 8, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 4, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance